Clinical Trial Update: A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY3541860 in adults with relapsing multiple sclerosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• LY3541860

Snippet

Sponsor: Eli Lilly and Company | Conditions: Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING